{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:56:24Z","timestamp":1789509384621,"version":"build-2803163510"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T00:00:00Z","timestamp":1332720000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0032098","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T21:19:37Z","timestamp":1332796777000},"page":"e32098","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of a Deformable Atlas to Identify Cryptic Critical Structures in the Treatment of Glioblastoma Multiforme"],"prefix":"10.1371","volume":"7","author":[{"given":"David C.","family":"Weksberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Bilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,26]]},"reference":[{"key":"ref1","article-title":"Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004\u20132007.","year":"2011"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.","volume":"10","author":"R Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma.","volume":"352","author":"ME Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","article-title":"A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.","volume":"66","author":"RB Jenkins","year":"2006","journal-title":"Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/cncr.11187","article-title":"Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.","volume":"97","author":"MJ van den Bent","year":"2003","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2005.04.3414","article-title":"Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.","volume":"24","author":"G Cairncross","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1200\/JCO.2009.23.6497","article-title":"NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.","volume":"27","author":"W Wick","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07357900600970490","article-title":"Computer visualization techniques (CVTs) foster evidence-based target delineation.","volume":"25","author":"EB Butler","year":"2007","journal-title":"Cancer Invest"},{"key":"ref10","article-title":"Deformable Anatomic Templates Embed Knowledge into Brain Images: Part1.","author":"JD Hamilton"},{"key":"ref11","doi-asserted-by":"crossref","article-title":"Deformable Anatomic Templates Embed Knowledge into Brain Images: Part 2.","author":"JD Hamilton","DOI":"10.1097\/RCT.0b013e318245c21b"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2007.12.5062","article-title":"Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.","volume":"25","author":"GD Shah","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.","volume":"10","author":"EL Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.","volume":"295","author":"H Aoyama","year":"2006","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.","volume":"37","author":"L Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/0284186X.2011.584555","article-title":"Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.","volume":"50","author":"PM Rosenschold","journal-title":"Acta Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1754-9485.2011.02282.x","article-title":"Sparing of the hippocampus, limbic circuit and neural stem cell compartment during partial brain radiotherapy for glioma: A dosimetric feasibility study.","volume":"55","author":"JC Marsh","year":"2011","journal-title":"J Med Imaging Radiat Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/COC.0b013e318178e4e8","article-title":"A radiation oncologist's guide to contouring the hippocampus.","volume":"32","author":"BS Chera","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ijrobp.2010.01.039","article-title":"Hippocampal-sparing whole-brain radiotherapy: a \u201chow-to\u201d technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy.","volume":"78","author":"V Gondi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0032098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:11:21Z","timestamp":1540336281000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0032098"}},"subtitle":[],"editor":[{"given":"Kevin","family":"Camphausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,26]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0032098","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,26]]}}}